News & Analysis as of

Executive Orders Imports

Polsinelli

Court Strikes Down Fentanyl and Reciprocal Tariffs, but Appeals Court Temporarily Stays Impact

Polsinelli on

Key Takeaways - The U.S. Court of International Trade struck down President Trump’s fentanyl and reciprocal tariffs imposed under the International Emergency Economic Powers Act of 1977 (IEEPA), ruling the statute did not...more

K&L Gates LLP

The Trump Administration Announces Trade Agreement With China

K&L Gates LLP on

On Thursday, 8 May, shortly after the announcement of the trade agreement with the United Kingdom and the United States, US Trade Representative Jamieson Greer and Treasury Secretary Scott Bessent provided additional details...more

Gray Reed

Tariff Rollercoaster Continues as Court Overturns Trump Mandated Tariffs

Gray Reed on

Yesterday, May 28, 2025 the U.S. Court of International Trade delivered a landmark decision that could reshape the landscape of American trade policy and presidential authority. The court ruled that President Trump exceeded...more

Warner Norcross + Judd

The U.S. Court of International Trade Stops Several IEEPA Tariffs

Warner Norcross + Judd on

On May 28, the U.S. Court of International Trade in a case challenging tariffs issued under the International Emergency Economic Powers Act of 1977 (IEEPA) filed by V.O.S. Selections, Inc. and other plaintiffs, and joined in...more

Benesch

Syria Sanctions - New General License Issued by OFAC Following Trump Announcement

Benesch on

President Trump announced plans to relax sanctions against Syria during his recent trip to the Middle East, where he visited with the country’s President, Ahmed al-Sharaa. ...more

Husch Blackwell LLP

CBP Issues Guidance on Prioritization of Articles “Subject to” More Than One Tariff Under EO 14289

Husch Blackwell LLP on

On May 15, 2025, U.S. Customs and Border Protection (“CBP”) issued further guidance via the Cargo Systems Messaging Service (“CSMS”) for determining the order in which the various tariffs will apply to an article when that...more

Wilson Sonsini Goodrich & Rosati

Do April Tariff Showers Bring May Trade Deal Flowers?

Following the introduction and partial rescission of the “Liberation Day” tariffs last month, the latest U.S. government actions have largely—though not universally—continued down the path of an easing tariff burden. Of...more

Polsinelli

Trump Administration Announces New Executive Order to Promote Domestic Production of Biopharmaceuticals

Polsinelli on

Key Takeaways - Regulatory Relief for U.S. Manufacturing: The EO streamlines FDA and EPA processes to encourage domestic pharmaceutical production....more

McGuireWoods LLP

U.S. and China Move to Lower Tariffs, Relieve Supply Chain Pressures, Costs for Businesses

McGuireWoods LLP on

The United States and the Republic of China announced a significant step toward easing longstanding trade tensions, with both nations agreeing to lower a series of tariffs imposed during the ongoing trade dispute. The...more

ArentFox Schiff

As the (Customs and Trade) World Turns: May 2025

ArentFox Schiff on

Welcome to the May 2025 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and...more

Blake, Cassels & Graydon LLP

Legal Challenges to U.S. Tariffs Escalate

Since February 1, 2025, United States President Donald Trump has issued a number of executive orders imposing tariffs on countries around the world, including Canada. As the tariff landscape continues to shift, the number of...more

McDermott+

President Trump Issues Most Favored Nations Drug Pricing Executive Order

McDermott+ on

While much of Washington, DC’s attention this week has been focused on congressional action around budget reconciliation, including proposed changes to the Medicaid program, the White House also made news with release of a...more

White & Case LLP

United States and China Agree to Partially De-escalate April Tariffs

White & Case LLP on

On May 12, 2025, the United States and China issued a joint statement in Geneva outlining an agreement to de-escalate from the latest rounds of tariff increases. The arrangement reduces tariffs back to the levels of the...more

Akin Gump Strauss Hauer & Feld LLP

The Trump Administration Continues Focus on Drug Pricing with “Most-Favored-Nation Prescription Drug Pricing” Executive Order

On Monday, May 12, President Donald Trump signed an Executive Order (EO) titled, “Delivering Most-Favored-Nation Prescription Drug Pricing to Americans,” aimed at reducing prescription drug prices by implementing a...more

Troutman Pepper Locke

Temporary Reduction of Reciprocal Tariffs on Chinese Goods Following US-China Trade Truce

Troutman Pepper Locke on

On May 12, President Trump issued an executive order, “Modifying Reciprocal Tariff Rates to Reflect Discussions with the People’s Republic of China” (the Order), temporarily lowering reciprocal tariffs on Chinese imports that...more

Lathrop GPM

U.S.-China Trade Update: Trade Deal Brings Tariff and Policy Changes

Lathrop GPM on

This information was current as of 8:00 a.m. CT, May 15, 2025. We will update as changes occur. On May 12, 2025, the United States and China jointly announced a temporary trade agreement aimed at de-escalating ongoing...more

Holland & Knight LLP

Trump Administration Revives Most-Favored-Nation Drug Pricing: Here's What to Know

Holland & Knight LLP on

President Donald Trump on May 12, 2025, issued an executive order (EO) titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" and an accompanying Fact Sheet, "President Donald J. Trump...more

Cooley LLP

FDA Expands Unannounced Inspections at Foreign Manufacturing Facilities

Cooley LLP on

On May 6, the US Food and Drug Administration (FDA) announced plans to expand its use of unannounced inspections at foreign manufacturing facilities that “produce foods, essential medicines, and other medical products...more

Benesch

Trade Deal Q&A - China and UK Developments and Impacts

Benesch on

Potential clarity on reciprocal tariff expectations may be emerging after framework trade deals announced with China and the United Kingdom. On May 12, 2025, the White House issued a Fact Sheet and Executive Order (“EO”)...more

ArentFox Schiff

US-China Tariff Truce? 90-Day Pause Begins May 14

ArentFox Schiff on

On May 12, the United States and the People’s Republic of China announced a temporary 90-day agreement to roll back some of the reciprocal tariffs increases imposed in April. The agreement decreases the China reciprocal...more

Polsinelli

United States and China Announce Temporary 115 Percent Reduction in Tariffs While Trade Discussions Continue

Polsinelli on

After negotiations over the weekend in Geneva, Switzerland, the United States and China reached a new trade deal on Monday, May 12, 2025, to temporarily slash tariffs on each country’s goods by 115 percent for the next 90...more

Husch Blackwell LLP

U.S. and China Agree to Reduce Tariffs for 90 Days

Husch Blackwell LLP on

On May 11, 2025, the U.S. announced that it had reached an agreement with China to mutually reduce tariffs against each country for 90 days. The reduced rates, discussed below, will take effect for goods entered on or after...more

Kennedys

US Tariffs: the regulatory landscape, impact on trade and strategic guidance for clients in the commercial, maritime and insurance...

Kennedys on

Presidential authority & legal foundations for US tariff policies The legal framework governing tariffs in the US is rooted in the US Constitution, which grants Congress the power to levy tariffs. However, this authority has...more

Sheppard Mullin Richter & Hampton LLP

Onshoring Pharma Ops: Reading Recent EO and Policy Tea Leaves

Recently, underscoring a commitment to national security, the White House and the Food and Drug Administration (FDA) issued separate communications that aim to bolster domestic drug manufacturing while tightening oversight of...more

Morgan Lewis

From Offshore to Onshore: Considerations for Pharmaceutical Industry Stakeholders Amid New Domestic Drug Manufacturing EO

Morgan Lewis on

The White House on May 5, 2025 issued an executive order requiring the US Food and Drug Administration to find ways to facilitate the opening of new drug manufacturing sites in the United States while also increasing the...more

362 Results
 / 
View per page
Page: of 15

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide